ArticleJournal of cardiovascular development and disease2026

Real-World Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy: A Pharmacovigilance Study.

Gregory W Chai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.